Litigation Details for Tris Pharma Inc. v. Par Pharmaceutical Inc. (D. Del. 2015)
✉ Email this page to a colleague
Tris Pharma Inc. v. Par Pharmaceutical Inc. (D. Del. 2015)
Small Molecule Drugs cited in Tris Pharma Inc. v. Par Pharmaceutical Inc.
Details for Tris Pharma Inc. v. Par Pharmaceutical Inc. (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-01-21 | External link to document | |||
| 2015-01-20 | 1 | infringement of United States Patent No. 8,062,667 (“the ’667 patent”), United States Patent No. 8,287,903 (“the…extended release oral suspension United States Patent Nos. 8,062,667; 8,287,903; 8,465,765; 8,563,033 and 8,…extended release oral suspension United States Patent Nos. 8,062,667; 8,287,903; 8,465,765; 8,563,033 and 8,…infringed the ’667 patent, the ’903 patent, ’765 patent, the ’033 patent, and the ’390 patent by submitting… of the ’667 patent, the ’903 patent, ’765 patent, the ’033 patent, and the ’390 patent; (d) | External link to document | |
| 2015-01-20 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,062,667 B2; 8,827,903 B2; 8,465,765…2015 2 November 2015 1:15-cv-00068 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
